What is SELLAS Life Sciences Group, Inc.'s total cost of revenue?

SELLAS Life Sciences Group, Inc. (SLS) reported total cost of revenue of $0 in Q4 2023.

What is the long-term trend for SELLAS Life Sciences Group, Inc.'s total cost of revenue?

Over 2 years (2021 to 2023), SELLAS Life Sciences Group, Inc.'s total cost of revenue has grown at a -100.0% compound annual growth rate (CAGR), from $200K to $0.

What does total cost of revenue mean?

The aggregate of all direct costs attributable to producing goods and delivering services that generated the company's revenue, including materials, labor, and overhead.

SELLAS Life Sciences Group, Inc. SLS Total Cost of Revenue

Discontinued — last reported Q4 '23

Total Cost of Revenue at other companies

PfizerPFE

$3.55B+24.7%

AbbVieABBV

$4.22B+5.4%

IncyteINCY

$104.52M+42.8%

Iovance Biotherapeutics, Inc.IOVA

$42.5M-0.5%

ImmunityBio, Inc.IBRX

$238K+310%

Gilead SciencesGILD

$1.45B-6.2%

Other financials

Income statement

See full

Revenue-—

Gross profit-—

Operating income-$9.3M-52.6%

Net income-$8.4M-44.6%

EPS (diluted)-$0.05+28.6%

Balance sheet

See full

Cash & equivalents$107.1M+277%

Total debt$871.0K+0.1%

Total equity$107.4M+287%

Total assets$114.2M+227%

Cash flow

See full

Operating cash flow-$8.8M+2.5%

Valuation

See full

Market cap$1.78B+674%

Enterprise value$1.68B+826%

Profitability

See full

Gross margin90%-7.4pp

Operating margin-4,195%-4,591pp

Net margin-4,130.1%-4,444pp

FCF margin-300.5%—

Returns & leverage

See full

Return on equity-43.6%-17.9pp

Debt / equity0×0.0×

Current ratio17.2×+12.6×

Where this comes from

Reported directly by SELLAS Life Sciences Group, Inc. in its filing.

Tagged under the XBRL concept us-gaap:CostOfGoodsAndServicesSold.

The official record: SELLAS Life Sciences Group, Inc.’s 10-K, filed March 28, 2024, on SEC EDGAR. View the filing →

Ask your AI about SELLAS Life Sciences Group, Inc.'s total cost of revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is SELLAS Life Sciences Group, Inc.'s total cost of revenue?: SELLAS Life Sciences Group, Inc. (SLS) reported total cost of revenue of $0 in Q4 2023.
What is the long-term trend for SELLAS Life Sciences Group, Inc.'s total cost of revenue?: Over 2 years (2021 to 2023), SELLAS Life Sciences Group, Inc.'s total cost of revenue has grown at a -100.0% compound annual growth rate (CAGR), from $200K to $0.
What does total cost of revenue mean?: The aggregate of all direct costs attributable to producing goods and delivering services that generated the company's revenue, including materials, labor, and overhead.